As filed with the Securities and Exchange Commission on November 22, 2004
Registration No. 333-76954
SECURITIES AND EXCHANGE COMMISSION
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-8
REGISTRATION STATEMENT
Under
THE SECURITIES ACT OF 1933
ATRIX LABORATORIES, INC.
Delaware (State or other jurisdiction of incorporation or organization) |
84-1043826 (I.R.S. Employer Identification No.) |
2579 Midpoint Drive
Fort Collins, Colorado 80525
(970) 482-5868
(Address of Principal Executive Offices including Zip Code)
2000 Stock Incentive Plan
1999 Non-Employee Director Stock Incentive Plan
Non-Qualified Stock Option Plan (as amended)
Amended and Restated Performance Stock Option Plan (as amended)
(Full title of the plans)
Michael R. Duncan
President
ATRIX LABORATORIES, INC.
2579 Midpoint Drive
Fort Collins, Colorado 80525
(970) 482-5868
(Name, Address, Including Zip Code, and Telephone Number,
Including Area Code for Agent for Service)
Copy to:
Ora T. Fisher, Esq.
Nicholas S. OKeefe, Esq.
Latham & Watkins LLP
135 Commonwealth Drive
Menlo Park, California 94025
(650) 328-4600
DEREGISTRATION OF COMMON STOCK
On October 4, 2000, the Registrant filed with the Securities and Exchange Commission (the Commission) a registration statement on Form S-8, Registration No. 333-76954 (the Registration Statement), for the sale of 2,068,560 shares of the common stock (the Common Stock), par value $.001 per share, of the Registrant under the Registrants 2000 Stock Incentive Plan, 1999 Non-Employee Director Stock Incentive Plan, Non-Qualified Stock Option Plan (as amended) and Amended and Restated Performance Stock Option Plan (as amended) (collectively, the Plans).
On November 19, 2004, pursuant to the terms of the Agreement and Plan of Merger (the Merger Agreement), dated as of June 14, 2004, by and among the Registrant, QLT Inc. and Aspen Acquisition Corp., a wholly-owned subsidiary of QLT Inc., Aspen Acquisition Corp. merged with and into the Registrant, and the Registrant became a wholly-owned subsidiary of QLT Inc. Each share of Common Stock outstanding immediately prior to the effective time of the merger was converted into the right to receive one QLT common share and US$14.61 in cash, without interest. Because the Registrant is no longer a public company, this Post-Effective Amendment No. 1 is being filed to deregister all of the unissued shares of Common Stock formerly issuable under the Plans and registered under the Registration Statement.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing this Post-Effective Amendment No. 1 to Form S-8 and has duly caused this Post-Effective Amendment No. 1 to Form S-8 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Fort Collins, State of Colorado, on this November 22, 2004.
ATRIX LABORATORIES, INC. |
||||
By: | /s/ Michael R. Duncan | |||
Michael R. Duncan | ||||
President | ||||
Pursuant to the requirements of the Securities Act of 1933, this Post-Effective Amendment No. 1 to Form S-8 has been signed by the following persons in the capacities and as of the dates indicated.
Signature |
Title |
Date |
||
/s/ Michael R. Duncan
Michael R. Duncan |
President (Principal Executive Officer) and Director | November 22, 2004 | ||
/s/ Gregory A. Gould
Gregory A. Gould |
Chief Financial Officer, Treasurer and Secretary (Principal Financial Officer and Principal Accounting Officer) | November 22, 2004 | ||
/s/ Paul J. Hastings
Paul J. Hastings |
Director | November 22, 2004 | ||
/s/ Eric Dadey
Eric Dadey |
Director | November 22, 2004 |